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Abstract
Background: The pericardial tissue is commonly used to produce bio-prosthetic cardiac valves and patches in cardiac
surgery. The procedures adopted to prepare this tissue consist in treatment with aldehydes, which do not prevent post-
graft tissue calcification due to incomplete xeno-antigens removal. The adoption of fixative-free decellularization protocols
has been therefore suggested to overcome this limitation. Although promising, the decellularized pericardium has not yet
used in clinics, due to the absence of proofs indicating that the decellularization and cryopreservation procedures can
effectively preserve the mechanical properties and the immunologic compatibility of the tissue.
Principal Findings: The aim of the present work was to validate a procedure to prepare decellularized/cryopreserved
human pericardium which may be implemented into cardiovascular homograft tissue Banks. The method employed to
decellularize the tissue completely removed the cells without affecting ECM structure; furthermore, uniaxial tensile loading
tests revealed an equivalent resistance of the decellularized tissue to strain, before and after the cryopreservation, in
comparison with the fresh tissue. Finally, immunological compatibility, showed a minimized host immune cells invasion and
low levels of systemic inflammation, as assessed by tissue transplantation into immune-competent mice.
Conclusions: Our results indicate, for the first time, that fixative-free decellularized pericardium from cadaveric tissue donors
can be banked according to Tissue Repository-approved procedures without compromising its mechanical properties and
immunological tolerance. This tissue can be therefore treated as a safe homograft for cardiac surgery.
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Introduction
Pericardium is employed in cardiac surgery to repair congenital
heart defects or to perform valve reconstruction. In addition,
pericardium of animal origin (pig, cow) is the elective material to
fabricate bio-prosthetic valves to be employed in surgical
replacement of insufficient and/or stenotic valves. Indeed, thanks
to its abundant collagen bundles and elastic fibers composition,
pericardium has a relatively high resistance to mechanical stress,
comparable to that of the native heart valves leaflets.
The technology commonly used to produce heart valves leaflets
from animal-derived pericardium consists in treating the tissue
with low concentration aldehydes (e.g. glutaraldehyde, GA),
necessary to create chemical bonds among the extracellular
matrix (ECM) components, thereby further increasing the tissue
mechanical resistance, and to prevent acute host immune rejection
[1]. On the other hand, aldehyde treatment has also drawbacks
regarding the tissue long-term durability. In fact, clinical data from
long term follow up of patients receiving pericardium-made bio-
prosthetic valves, has clearly indicated a severe impact of structural
valve deterioration (SVD) and calcification, due to permanence of
fixative remnants having potent cytotoxic effects. In addition, GA
fails in removing animal-specific antigens such as the (a1, 3)-Gal
epitope [2–6], which elicits chronic rejection of the implanted
prostheses. Importantly, the impact of SVD is highly correlated to
the age of recipients, with younger patients being un-favored - and
needing redo strategies - as early as 10–15 years following the first
surgery in a significant number of cases [7,8].
In order to overcome these limitations, basic research has
actively pursued fixation-free protocols (i.e., avoiding the use of
aldehydes) aimed at enhancing pericardial tissue durability. In
particular, novel decellularization methods have been proposed,
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based on treatment with hypotonic ‘‘decellularization’’ buffers,
containing detergents and DNA/RNA digesting enzymes to
eliminate cell debris and the remaining nucleic material from
the tissue. These strategies have been employed in the production
of both animal [9] and human-derived [10,11] pericardium with
relevant implications for clinical use. Moreover, they have been
proposed for the generation of tissue engineered heart valves
(TEHVs) [12].
Despite a very active research in this field, animal-derived and
human-derived decellularized pericardium have not been yet
introduced in the routine clinical practice. This also depends on
the absence of convincing evidences that this tissue may be
prepared and cryopreserved according to Tissue Repository-
compliant procedures, without compromising its mechanical
properties and immunological tolerance. In the present study,
we aimed at filling this technological gap by setting up a fixative-
free decellularization process followed by tissue cryopreservation
procedure of human pericardial tissue obtained by cadaveric tissue
donors. We validated our protocol with specific histological and
biomechanical analysis of the tissue, which revealed, i) a preserved
structure of the collagen bundles and elastin fibers, and ii) the
maintenance of suitable mechanical properties. Remarkably, the
immunological compatibility of decellularized/cryopreserved peri-
cardium was proven by subcutaneous transplantation for up to 60
days into immune-competent mice. From these results, we
conclude the feasibility of a Tissue Repository approved procedure
for the decellularization and cryopreservation of pericardial
samples from tissue donors that may be released as a novel
homograft tissue.
Results
Maintenance of tissue integrity and complete genetic
material removal by fixative-free decellularization
procedure
Histological analysis (Fig. 1A, 1B and 1C) was used as a first line
of inspection to qualitatively assess, i) the efficiency of cells removal
after decellularization, ii) the degree of the tissue histo-architecture
preservation, and iii) the content and distribution of the collagen
bundles and elastic fibers in the extracellular matrix (ECM). In
detail, Masson’s staining of decellularized (DE) or decellularized/
cryopreserved (DE/CR) pericardium transversal histological
sections showed a complete removal of cells. The treatment was
not found to cause major deterioration of the tissue, as witnessed
by preservation of collagen bundles and elastic fibers. In addition,
DE or DE/CR samples did not appear swollen compared with
fresh tissue. To verify the removal of cells, staining with Hoechst
33258 of the histological sections was also performed [10],
followed by fluorescence microscopy analysis. As shown in
Figure 2A, this showed an efficient removal of cells, with no
evidence of cellular or nuclear residues observed in the sections.
Absence of remaining genetic material from DE/CR samples was
confirmed by Real Time-PCR on DNA extracted from three
pericardium samples, using primer couples specific for the hMYO-
D, hGAPDH and hNFkB genes promoter/coding sequences
(Figure 2B, Table 1).
Mechanical integrity of human pericardium after
cryopreservation procedure
Uniaxial tensile loading (UTL) tests were carried out on fresh,
DE and N2 vapors-cryopreserved DE pericardium (DE/CR)
samples to quantitatively characterize the biomechanical proper-
ties of the tissue. In particular, we used UTL tests to reveal any
potential alteration of the biomechanical characteristics of the
Figure 1. Histological appearance and decellularization of
pericardial samples. (A, B, C) Masson’s trichrome staining of the
pericardial tissue before (A), after decellularization (B) and after
decellularization/cryopreservation (C). Upper pictures in each panel
show low magnification of the tissue, while lower pictures show
magnification of the boxed areas. In these pictures it is evident that
decellularization did not affect the structure of collagen bundles (*) and
of elastic fibers (arrows). Bv: blood vessels.
doi:10.1371/journal.pone.0064769.g001
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tissue induced by the cryopreservation procedure. Figure 3A–D
shows the preparation steps of pericardial specimens for UTL
tests, while 3E represents three typical stress/strain curves
obtained from fresh, DE and DE/CR specimens strained to
rupture. The stress-strain behavior for each specimen of the three
groups was analyzed by means of six parameters [13], including:
the elastic modulus (i.e., the stress-strain curve slope) at low (Elow)
and high strain (Ehigh), representative of the tissue resistance due to
the contribution of the elastin and collagen fibers composing the
ECM, respectively; the tensile stress (strans) and strain (etrans)
values at the transition between the elastin and collagen stress-
strain curve slope; the maximum tensile stress (smax) and strain
(emax) characterizing the failure phase of the tissue sample. The
comparison of the six parameters in fresh vs. DE and DE/CR
groups did not show statistically significant differences (Fig. 3F),
suggesting that the procedure adopted to obtain the decellularized
pericardium not modify the tissue resistance to mechanical strain.
This result suggests that the integrity and the arrangement of
ECM components were maintained in DE and DE/CR pericar-
dium samples, ensuring a biomechanical performance similar to
that of native tissue.
Immunological compatibility of decellularized
pericardium, before and after cryopreservation
The immunological compatibility of human- and animal-
derived pericardium has been previously tested by transplantation
in animals, where the reaction of the host against the graft, and the
graft calcification were assessed mainly by ex-post histological
analysis of inflammatory/immune cells invasion [11,14–16]. To
assess whether the decellularization and the decellularization/
cryopreservation procedure of the human pericardium adopted in
the present study led to changes in the tissue immune-tolerance,
we adopted a similar strategy. Fresh, DE and DE/CR pericar-
dium fragments were transplanted in subcutaneous position into
immune-competent mice for 30 and 60 days followed by histology,
immunohistochemistry and analysis of inflammatory-competent
cells in peripheral circulation. As shown in Figure 4A, the
histological appearance of DE and DE/CR samples was strikingly
different from that of the fresh tissue. In fact, high levels of round
cells with macrophage/lymphocyte morphology, forming deep
layers of granulation tissue were observed in fresh pericardium
samples; by contrast an overall lower number of cells with a
predominant spindle-shape morphology and elongated nuclei, was
observed in in DE and DE/CR samples. Of note, foci of donor-
derived inflammatory cells infiltration and tissue matrix reabsorp-
tion were never observed in any of the DE and DE/CR samples
explanted from mice at both time points, indicating a high - but
not different - degree of compatibility of DE and DE/CR vs. fresh
Figure 2. Efficiency of the decellularization process. (A) Hoechst
33258 staining was used to histologically assess the performance of the
decellularization process. The upper panels show the overlapped bright
field and Hoechst dye channels of the fresh and DE tissues without
counterstaining, while lower panels show the dark field image of the
Hoechst dye channel only in the same microscopic field. The lack of any
signal in DE samples indicates a complete removal of double strand
DNA from the tissue. (B) Q-PCR on DNA extracted from fresh and DE/CR
samples shows complete removal of DNA by decellularization
procedure using primers specific for the hMYO-D, hGAPDH and hNFkB
genes promoter/coding sequences. The upper panel shows a repre-
sentative amplification plot from one of the three FRESH samples with
each primers pair, while the curves under the green bar are under-
threshold signals generated by the corresponding DE/CR sample. The
lower panel shows an agarose gel run of the PCR amplification
products; as expected, no amplification bands were obtained by none
of the DE/CR samples.
doi:10.1371/journal.pone.0064769.g002
Table 1. CT values (mean6SE) obtained by real time PCR
amplification of DNA extracted from FRESH and DE/CR
samples.
CT (mean±SE)
GENE FRESH DE/CR
MYO-D 19,2560,54 0
GAPDH 26,8262,83 0
NFkB 18,6860,53 0
Each amplification was performed in duplicate using 3 independent FRESH and
DE/CR samples.
doi:10.1371/journal.pone.0064769.t001
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pericardium. To confirm the overall lower infiltration by host cells,
an automatic counting of cellular nuclei was performed in fixed
area images (0.15 mm2) of hematoxyilin/eosin stained sections of
fresh, DE and DE/CR samples. Results of this survey confirmed
an overall lower presence of cells in DE and DE/CR compared
with fresh pericardial samples (Fig. 4B).
We and others have found that patients receiving allograft valve
transplantation show increased serum levels of anti HLA-1
antibodies [17] and of circulating cytotoxic and helper T-
lymphocytes (CTLs, HTLs) [18,19].
Since an elevation of inflammatory markers and immune cell
circulation has been indicated as one of the main causes of SVD, a
time course analysis of circulating T-lymphocytes was performed
in blood samples obtained from mice receiving fresh, DE and DE/
CR pericardium at 15, 30, 45 and 60 days after implantation. As a
reference for the dynamics of the T-cell mediated rejection of
pericardial tissue, the relative ratio of the CD4+/CD8+ lympho-
cytes was calculated after appropriate recognition of total
circulating T-lymphocytes stained with the pan T-cell marker
CD3. As shown in Figure 5, a statistically significant decrease of
this ratio, caused by a relative increase of circulating CD8+ cells,
was observed at all times in mice receiving fresh pericardial
samples. By contrast, a constant CD4+/CD8+ cell ratio around or
above 3 was observed in mice implanted with DE or DE/CR,
suggesting absence of a strong T-cell-mediated immune response.
Finally, no statistically significant difference between DE and DE/
CR receiving mice was observed, suggesting that cryopreservation
did not alter the immunological compatibility of human decel-
lularized pericardium.
The host immune response has a striking impact on in vivo
durability of GA-fixed and fixative-free bio-prosthetic valve grafts,
due to chronic inflammatory process [20] and calcification [21],
which leads to progressive SVD and decay of mechanical
performance. To reveal the inflammatory cellular species invading
the implanted pericardium specimens, an immunohistochemistry
staining of fresh, DE and DE/CR samples was performed using
anti mouse CD3 and CD11b antibodies, which recognized host-
derived lymphocytes and macrophages, respectively (Fig. 6A). The
results showed the presence of an elevated number of CD3+ and
CD11b+ cells in fresh pericardial samples explanted at 30 and 60
days; these numbers were significantly higher than in DE or DE/
CR explanted pericardial tissue (Fig. 6B). Interestingly, a lower T
cells number in fresh pericardium was observed at 60 compared
with 30 days, suggesting an attenuation of the host T-cell-mediated
immune rejection at longer times post-implantation. A similar
decrease in macrophages (CD11b+ cells) content was not observed,
showing a sustained innate immunity response.
Finally, to assess whether calcification secondary to inflamma-
tory/immune response occurred in the transplanted pericardial
specimens, Von Kossa staining was performed on histologic
Figure 3. Uniaxial mechanical testing of fresh, DE and DE/CR pericardial samples. (A–D) Preparation steps of pericardial specimens; intact
pericardium (A), strips of pericardium (B), dog-shaped specimens obtained from the strips (C), specimen mounted into the clamps of the uniaxial test
machine (D). (E) Representative curves showing the stress/strain relationship of fresh, DE and DE/CR samples. (F) Graphical representation of the six
mechanical parameters obtained for fresh, DE and DE/CR samples: elastic modulus at low (Elow) and high (Ehigh) strain values, transition stress (strans)
and strain (etrans), maximum tensile stress (smax) and strain (emax). Results are graphically represented with inter-quartile range box plots and whiskers
indicating 10th and 90th percentile, plus outlier values (N). Continuous lines in box plots indicate median values of each data set, while crosses
indicate mean of the same data. None of these values in DE or DE/CR samples were significantly different from fresh tissue values as verified by
Kruskall-Wallis test (n = 15, fresh samples; n = 36, DE samples; n = 41, DE/CR samples; pericardial tissues from 3 independent cadaveric donors).
doi:10.1371/journal.pone.0064769.g003
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sections of tissue explants at 60 days post-surgery. As shown in
Figure S1, no staining was observed in DE or DE/CR explanted
samples; small calcium deposits were occasionally found in fresh
pericardium specimens recovered after 60 days, showing that
inflammatory response was not associated to major pericardium
calcification in any of the conditions considered in the present
study.
Discussion
Devising novel procedures to produce replacement allograft or
bio-prosthetic valve conduits offers significant expectations to
ameliorate the clinical outcome of the current heart valves disease
treatments. In fact, the durability of these devices is still
unacceptably limited, with an elevated burden for the patients’
quality of life. As an example, studies reporting the clinical
outcome of patients receiving bio-prosthetic valve implants clearly
indicated a progressive SVD due to host inflammatory response
and immune rejection. Strikingly, the clinical data indicated a
higher propensity of younger subjects susceptible to develop
implant failure more rapidly than older patients and thus requiring
re-operation [7,8]. Depending on the type of the employed
prostheses, different causes are at the basis of the insufficient
durability. For example, the employment of non-decellularized/
cryopreserved valve homografts obtained from cadaveric tissue
donors does not resolve the problem of the allogenic (man to man)
immune response [20], while the employment of the so called
‘‘biological’’ valves - valve conduits of animal origin (porcine
valves) or bio-prosthetic valves fabricated with leaflet mimicking
biological tissues (typically pig and cow pericardium) - has its
major limitation in the use of GA-based fixation protocols, which
leave residual free aldehyde groups in collagen abundant tissues
[22], form chemical bonds between ECM components, and fail in
removing xeno-antigens such as the (a1, 3)-Gal epitope [5,6],
recognized as ‘‘non-self’’ by the human species. Although
advanced protocols to reduce the overall cytotoxicity of GA-fixed
tissues have been devised [14,16,23–25], novel procedures to
prepare leaflet and pericardial tissue patches preventing the use of
aldehydes have been also explored. These procedures are based on
decellularization of the tissue through osmotic lysis followed by
exposure to ionic (e.g. SDS) and/or non-ionic (e.g. Triton-X 100)
detergents to efficiently remove cell remnants. The apparent
advantage of these procedures over the GA-based fixation is the
lack of aldehyde residues, the absence of chemical bonds between
ECM components, and the removal of xeno-antigens. On the
other hand, whether decellularized tissues have or not an
improved immunologic compatibility and an optimal mechanical
performance is still matter of debate requiring further investigation
[4,9,26].
Figure 4. Gross morphology and host cell invasion quantitative analysis at 30 and 60 days following fresh, DE and DE/CR tissues
implantation into imunocompetent mice. (A) Left panels show low magnification of fresh, DE and DE/CR pericardium after recovery from the
subcutaneous position at 60 days. It is evident an overall higher number of cells in fresh vs. DE and DE/CR samples. Foci of inflammation with signs of
tissue absorption were often observed in fresh samples, while these were never found in both DE and DE/CR tissues, indicating lower rejection.
Panels on the right show high magnification of the yellow-boxed areas in left panels. It is evident that in fresh samples, infiltration was mainly due to
cells with round nuclei, resembling inflammatory cells (green arrows), while the majority of infiltrating cells in DE and DE/CR pericardium specimens
had elongated nuclei, resembling fibroblasts (red arrows). (B) Quantification of infiltrating cells was performed by computer assisted nuclei counting
after appropriate filtering of the B/W images. Picture at the top is a 0.15 mm2 micrograph where nuclei were automatically recognized and contoured
in yellow by Image-J software; box-plot in the bottom indicates the results of nuclei counting at 30 and 60 days in fresh, DE and DE/CR samples.
Results are graphically represented with inter-quartile range box plots and whiskers indicating 10th and 90th percentile. Continuous lines in box plots
indicate median values of each data set, while crosses indicate mean of the same data. * indicates P,0.05 for statistical comparison of fresh vs. DE
and DE/CR samples at both time points by Kruskall-Wallis test with Dunn’s post-hoc analysis (5#n#8).
doi:10.1371/journal.pone.0064769.g004
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To our knowledge, human-derived pericardium decellularized
with an osmotic/detergent-based procedure has not yet clinically
employed. In fact, preservation of mechanical properties and in
vivo compatibility of this tissue were previously assessed [10,11];
however, the absence of data related to the maintenance of the
tissue material properties after a cryopreservation storage period
does not allow conclude whether this tissue may be eventually
routinely prepared, banked and distributed by officially recognized
homograft Repositories. This particular issue is not trivial. In fact,
similar to the production process of cells for cell-based therapy
according to the Good Manufacturing Practice [27], the
homografts approval for clinical employment requires crucial
validation steps to demonstrate the biological and the functional
integrity of the tissue. In this regard, the UTL tests performed in
the present study (Figure 3) showed that none of the parameters
describing the mechanical properties of the human pericardium
were modified by the decellularization or the decellularization/
cryopreservation procedure. Thus, our data extend the observa-
tions by Mirsadraee et al. [10] and underline the relevance of
fixation-free decellularization procedures to prepare human
pericardium with intact mechanical properties for future clinical
employments.
The result of subcutaneous implantation into immune-compe-
tent mice was performed taking as a reference the human fresh
pericardium. This was done to assess the efficiency of the
decellularization protocol at removing cellular material represent-
ing a source of allogenic tissue rejection, or promoting secondary
calcification. As shown in Figure 4, the overall invasion by host
cells was significantly lower in mice receiving DE and DE/CR
tissue samples; moreover, in both cases, the number of infiltrating
cells was significantly lower than in mice implanted with fresh
pericardium. In addition, DE and DE/CR samples showed no
signs of reabsorption and formation of granulomas. This finding is
in line with the lower numbers of CD3+ cells and CD11b+ cells in
DE and DE/CR compared with the fresh pericardium (Fig. 6)
[11]. To further explore the role of systemic inflammation in mice
implanted with human pericardial samples, the ratio of circulating
CD4+/CD8+ lymphocytes, a parameter that is commonly taken as
a reference to monitor rejection in solid organ transplantation [28]
and mouse models [29], was also determined. These tests (Fig. 5)
revealed a striking increase in the relative amount of circulating
CD8+ cells as early as at 15 days post-implantation in mice
receiving the fresh pericardium, suggesting a rapid initiation of the
rejection process. By contrast, DE and DE/CR pericardial
implants were never found to cause an imbalance in lymphocytes
ratio for the whole duration of the experiment. Although we did
not specifically investigate the subclasses of CD8+ circulating cells,
this observation appears particularly relevant in the view of
homograft transplantation of the DE/CR tissue. In fact, GA-fixed
pericardial implants are known to cause an increase of circulating
cytotoxic [18] or helper [19] T cells and production of anti HLA-I
antibodies, which correlate with graft failure [17]. Thus, the
fixative-free decellularization/cryopreservation method used in
the present study may be helpful to reduce the inflammatory and
cell-mediated immune response in recipients, improving the long-
term durability of the implants.
In summary, thanks to unaltered mechanical properties, the
potentially reduced cytoxicity and the lowered immunogenicity,
Figure 5. Dynamics of CD3+, CD4+ and CD8+ cells mobilization in mice implanted with fresh, DE and DE/CR samples. (A)
Representative flow cytometry detection of CD3+ (left contour plots column), CD4+ (center contour plots column) and CD8+ (right contour plots
column) circulating cells in a mouse receiving a non decellularized (FRESH) pericardial sample at 0, 15, 30, 45 and 60 days. CD3+, CD4+ and CD8+ cells
are indicated, respectively by blue, red and green contours on the right of the main PBMNCs population (grey contours), established by staining with
isotype control antibodies. (B) CD4+/CD8+ lymphocytes ratio was determined at all the time points and plotted. Mice receiving fresh pericardium
showed a reduced ratio suggesting increase in the number of circulating T-lymphocytes implicated in T cell-mediated tissue rejection. * indicate a
statistical difference (P,0.05, by two-ways ANOVA with Bonferroni post-hoc test, n = 5) between the CD4/CD8 ratio in mice receiving fresh vs. those
implanted with DE and DE/CR tissues.
doi:10.1371/journal.pone.0064769.g005
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we propose the decellularized human pericardium produced with
the protocol described here as a novel and safe homograft tissue to
be clinically employed. In addition, since the adoption of fixative-
free decellularization strategies is recommendable for production
of biological-derived material for recellularization with living cells
and derivation of TEHVs [16,25,30–33], the procedure described
here may also be useful for devising novel living implants, with
higher degree of immunological compatibility and lower potential
for SVD, with significant benefits for the patients.
Materials and Methods
Ethics statement
Human pericardial samples were obtained as discharge material
during heart dissection in the routine processing of valve
homografts preparation at the Lombardy Cardiovascular Tissue
Repository, the official Lombardy’s Facility for collection of
cadaveric cardiovascular tissues and cardiovascular homograft
preparation and storage (www.cardiologicomonzino.it/Clinica/
ChirurgiaCardiovascolare); authorization number: DGR VII/
12848 (April 28, 2003 – Official Lombardy Bullettin). Samples
from a total of six cadaveric tissue donors were used in the present
study. Collection of hearts from these donors was performed after
signature of an approved informed consent by donor relatives.
The procedures concerning animal care, surgery, and eutha-
nasia were carried out in accordance to the ‘‘Guide for the Care
and Use of Laboratory Animals’’ and the Helsinki declaration.
They were further compliant with European directives and
guidelines (Legislative Decree September 19, 1994, n. 626; 89/
391/CEE, 89/654/CEE, 89/655/CEE, 89/656/CEE, 90/269/
CEE, 90/270/CEE, 90/394/CEE, 90/679/CEE). The proce-
dures used in the present study, were further approved and
authorized by the Italian Ministry of Health and the University of
Milan Ethical Committee (approval number:1242003-A 13/10/
2003).
Decellularization procedure and histology
In the present study, a decellularization procedure similar to
that developed by Mirsadree et al. [10,11] was adopted. After an
accurate surgical elimination of fat, pericardial tissue was first
washed for 90 min in phosphate-buffered saline (PBS) containing
protease inhibitors (aprotinin, 10 KIU/ml, Trasylol, Bayer,
Germany; 0.1% w/v EDTA, BDH, Lutterworth, United King-
dom) under continuous agitation, and with buffer changing every
30 min. To achieve cells removal from the tissue, the tissue was
treated with hypotonic buffer (10 mM Tris-HCl; pH 8.0) for 16 h
under continuous agitation at 4uC in the presence of protease
inhibitors, followed by incubation for 24 h in 0.1% (w/v) sodium
dodecylsulphate (SDS) in hypotonic buffer at room temperature
under continuous agitation. To remove nucleic acid material, the
samples were washed in sterile PBS three times for 30 min under
agitation and incubated for 3 h at 37uC in a reaction buffer
containing 50 U/mL deoxyribonuclease I from bovine pancreas
[DNase, Sigma- Aldrich, Germany] and 1 U/mL ribonuclease A
Figure 6. Infiltration of the implanted pericardial tissue by CD3+ lymphocytes and CD11b+ macrophages. (A) Representative images of
fresh, DE and DE/CR pericardium tissue sections recovered by a mouse at 60 days and stained with CD32 and CD11b-specific antibodies. Black
arrows and red arrows indicate, respectively CD3+ and CD11b+ cells present in the tissue. Note the higher number of cells in fresh pericardial
specimens compared to DE or DE/CR samples. (B) Quantification of CD3+ (upper plot) and CD11b+ cells (lower plot) by software-assisted manual
counting (Image J) into fixed (0.039 mm2) tissue sections areas. At both time points the number of CD3+ and CD11b+ cells was significantly higher in
mice receiving fresh vs. DE or DE/CR pericardium (* indicate P,0.05 by 1-way ANOVA with Newman-Keuls post-hoc; n = 12). Interestingly, the number
of lymphocytes was significantly lower at 60 days compared with 30 days in mice receiving fresh pericardium ($ indicates P,0.05 by Mann-Whitney
rank sum test; n = 12).
doi:10.1371/journal.pone.0064769.g006
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from bovine pancreas [RNase, USB] in 10 mM Tris-HCl (pH 7.5;
Sigma-Aldrich) under gentle agitation on a gyrorocker. Finally,
samples were washed in PBS for three periods of 30 min under
agitation. To check the completeness of cell removal, pericardial
tissue was fixed immediately after the end of the decellularization
procedure and embedded into paraffin. Tissue sections (4–6 mm)
were cut and stained with ematoxylin/eosin, Masson’s trichrome
solution, Von Kossa staining solution, or with Hoechst 333258
nuclear dye.
DNA extraction and Q-PCR methods
Total DNA was isolated with TriPure Isolation Reagent (Roche
Applied Science) from 100 mg of fresh and DE pericardium
samples. Gycogen was added to samples before precipitation to see
pellets. Quantitative real-time PCR (qRT-PCR) amplifications
were carried out for MYOD, GAPDH and NFkB gene promoters
using Power SYBR Green PCR Master Mix (Applied Biosystems)
on a 7900 Fast Real-Time PCR System (Applied Biosystems).
Primer sequences were as follows:
hMYOD promoter: sense-59-CCTCTTTCGGTCCCT-
CTTTC-39, antisense-59-ATGGGTAGAGCGGCTGTAGA-39;
hGAPDH: sense-59-TACTAGCGGTTTTACGGGCG-39,
antisense-59 –TCGAACAGGAGGAGCAGAGAGCGA-39;
hNFkB promoter: sense-59-CAGCCGATGAGAGCCGG-
CAG-39, antisense-59-CCGGACCTCCCAGCCTGACA-39.
Cryopreservation and thawing
Pericardium samples were frozen and thawed according to the
procedures used by Lombardia Cardiovascular Tissue Bank.
Briefly, samples were frozen in a double sterile bag containing
freezing solution (RPMI 1640 plus 10% of DMSO) by the use of
liquid nitrogen ultra-low-temperature cooler (Planer - SOL S.p.A.,
Milan, Italy) and stored in N2 vapors in temperature range
between 2140uC and 2185uC. The samples were thawed inside
the sterile bag and washed three times in fresh RPMI 1640 [34,35]
immediately before use.
Mechanical testing
Uniaxial tensile loading (UTL) was performed on native (fresh),
decellularized (DE) and decellularized/cryo-preserved (DE/CR)
pericardial samples. Before the test, the samples were maintained
immersed in saline solution at 4uC. Dog-bone shaped specimens of
4 mm width and 20 mm height were dissected; in detail, 15, 36
and 41 specimens were retrieved and tested from the fresh, DE
and the DE/CR groups, respectively. No preferential orientations
were considered when cutting the specimens, assuming pericardi-
um isotropy [10,36]. The thickness of each specimen was
measured by means of a micrometer (0.05 mm of scale) in 3
different positions along the specimen height and the mean value
(tav) was used for mechanical parameters calculation. The
specimens were then mounted onto the clamps of the testing
machine; a sandpaper frame was constructed around the specimen
to facilitate uniform gripping and to avoid sample slippage [37].
Tissue specimens were preloaded up to 0.01 N and subjected to a
number of preconditioning loading-unloading cycles (ranging from
6 to 8 cycles), at 15% maximum strain with an elongation rate of
10 mm/min, until the loading-unloading curves were almost
superimposed. After tissue preconditioning the specimen was
preloaded up to 0.01N, the specimen initial length (l0) was
measured, and UTL test conducted until specimen failure, at a
constant velocity of 10 mm/min. The samples were maintained
immersed in PBS at 4uC until the UTL tests begun. All the tests
were performed at room temperature and the specimens were
maintained hydrated with PBS for the whole test duration.
The load (F) and displacement (l) data were acquired from the
load cell and the stroke of the cross-head of the testing machine
and the engineering stress (s) and strain (e) were calculated for
each data point, according to equation 1 and 2:
s~F=A ð1Þ
e~(l{l0)=l0 ð2Þ
where A is the cross-sectional area of the specimen at zero strain,
expressed as (eq. 3):
A~wxtav ð3Þ
with, w, tav and l0 representing the specimen width, average
thickness, and length at zero strain, respectively.
The stress strain behavior was described by means of 6
parameters according to Korossis et al. [13]: elastic modulus at
low (Elow) and high (Ehigh) strain values, transition stress (strans)
and strain (etrans), maximum tensile stress (smax) and strain (emax).
The biomechanical parameters calculated for verifying pericardi-
um mechanical properties are based on engineering stress and
strain values assuming that the cross-sectional area reduction is
negligible during specimen deformation. Even if the real
calculated stress, considering the cross-sectional reduction of the
specimens may be more accurate, its measurement requires the
use of optical-based systems, equipment not commonly integrated
in the standard UTL apparatuses. On the other hand, most of the
published UTL data consider the calculation of engineering stress
and strain [10,35,36,37].
Surgical procedures, peripheral blood collection,
pericardium recovery and image analysis
Subcutaneous implantation of pericardium fragments
(10610 mm) was performed in male CD1 mice (n = 54; 9 mice/
group) (Charles River, Calco Italy) of about 30gr weight. Before
implantation, mice were anesthetized with a ketamine (100 mg/
Kg) - xylazine (20 mg/kg) solution injected intraperitoneally; at
the same time, blood sampling was performed. Peripheral blood
was also collected in 5% EDTA containing tubes at 15, 30, 45 and
60 days after implantation following mild anesthesia with
isoflurane (1% in 100% oxygen, v/v). Pericardial tissue specimens
recovered at 30 and 60 days after implantation were placed into
4% buffered formalin immediately after recovery from the animals
and processed for conventional histological analysis (see before)
and immunohistochemistry. Tissue sections were observed under
light/fluorescence microscopes (Axiovert/Akioskop) equipped
with image analysis software (Zeiss, Cell Quest). Images were
acquired at a fixed magnification and analyzed using Image-J
software (http://rsbweb.nih.gov/ij), after appropriate grayscale
filtering, for automatic/manual nuclei/cells counting.
Immunohistochemistry
For immunohistochemistry, dewaxed and re-hydrated sections
(5 mm thick) were incubated with 5% bovine serum albumin (BSA)
in PBS to block nonspecific binding. The sections were then
immunostained with rabbit mAbs recognizing mouse CD3
(Abcam, Cambridge, UK, ab5690) or CD11b (Abcam, Cam-
bridge, UK, ab75476), followed by biotinylated goat anti-rabbit
IgG, using an avidin–horseradish peroxidase–biotin complex
method (Vector Laboratories, Burlingam, CA) and DAB or
NovaRed substrate (Vector Laboratories). A manual counting
Compatibility of Decellularized Pericardium
PLOS ONE | www.plosone.org 8 May 2013 | Volume 8 | Issue 5 | e64769
protocol of CD3+ and CD11b+ cells was performed by using
Image-J software.
Flow cytometric evaluation of circulating monocytes
Before staining with antibodies, blood was treated with
ammonium chloride to lyse red blood cells. Lymphocyte
population (CD3+ cells) and CD8+ cells were identified by staining
with allophycocyanin-conjugated anti-mouse CD3 (Ab553066),
and fluorescein-isothiocyanate-conjugated anti-mouse CD8
(Ab553031), while the percentage of CD4+ population was
evaluated by the use of phycoerythrin-conjugated anti-mouse
CD4 antibody (Ab553653). All antibodies were from BD
Biosciences, Milan, Italy. Cells were analyzed using a FACSCa-
libur flow cytometer (BD Biosciences, Milan, Italy). Data on
CD4+/CD8+ cells ratio were derived by acquisition of at least 104
events with appropriate logical gating of the CD3+ cellular
population.
Statistical analyses
Statistical comparisons were performed with Graph-Pad 5
(Prism) statistical software. All data were analyzed with Shapiro-
Wilk normality test. In case of normal data distribution, statistical
comparisons were performed using parametric tests - 1-way/
2ways ANOVA with Newman-Keuls/Bonferroni post-hoc analy-
sis. In case of non-normal data distribution, the statistical methods
used to compare data were the Kruskall-Wallis test with Dunn’s
multiple comparison post-hoc analysis or the Mann-Whitney rank
sum test. The methods adopted to perform statistical comparisons
are indicated in each figure legend.
Supporting Information
Figure S1 Von Kossa staining of fresh, DE and DE/CR
pericardium specimens recovered from mice at 60 days
following implantation. Except for few small calcium deposits
(arrows) in fresh samples, calcification was not observed.
(TIF)
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